Alumis is a biotechnology company focused on developing treatments for autoimmune disease, and their goal is to create therapies that are more precise than currently available autoimmune or immune-mediated disease treatments. Alumis was founded in 2021 and is headquartered in San Francisco, CA. Through its data analytics platform, Alumis seeks to enable researchers to match the right patients to targets, molecules, and combinations so they can create the best possible outcomes.

Register for Details

For more details on financing and valuation for Alumis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Alumis

Forge green plus iconForge green minus icon

What is Alumis's IPO price?

The IPO price for Alumis will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Alumis?

Alumis is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Alumis shares pre-IPO?

If you own Alumis pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Alumis a publicly traded company?

Alumis is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Alumis's funding to date?

Alumis has raised $638.43MM to date.
Forge green plus iconForge green minus icon

When was Alumis founded?

Alumis was founded in 2021.

Who are Alumis's major investors?

Foresite Capital
Cormorant Asset Management
Ally Bridge Group
Samsara Biocapital
Lilly Asia Ventures
Piper Sandler
HBM Healthcare Investments
SR One Capital Management
Omega Funds
Matrix Capital Management

Alumis funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C and C-1

$259MM raised $XXX.XX $XXX.XX

Series B-2 and B-2A

$98.89MM raised $XXX.XX $XXX.XX

Series B

$201MM raised $XXX.XX $XXX.XX

Series A and B-1

$69.04MM raised $XXX.XX $XXX.XX

Series Seed

$10.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.